Palomar Holdings, Inc. (NASDAQ:PLMR – Get Free Report) CEO Mac Armstrong sold 5,000 shares of the firm’s stock in a transaction on Thursday, February 12th. The shares were sold at an average price of $122.60, for a total value of $613,000.00. Following the sale, the chief executive officer directly owned 343,388 shares of the company’s stock, valued at $42,099,368.80. This represents a 1.44% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.
Mac Armstrong also recently made the following trade(s):
- On Saturday, January 31st, Mac Armstrong sold 2,205 shares of Palomar stock. The stock was sold at an average price of $121.74, for a total transaction of $268,436.70.
- On Saturday, January 31st, Mac Armstrong sold 2,205 shares of Palomar stock. The stock was sold at an average price of $121.74, for a total transaction of $268,436.70.
- On Thursday, January 29th, Mac Armstrong sold 5,399 shares of Palomar stock. The shares were sold at an average price of $122.04, for a total transaction of $658,893.96.
- On Thursday, January 29th, Mac Armstrong sold 5,399 shares of Palomar stock. The shares were sold at an average price of $122.04, for a total transaction of $658,893.96.
- On Wednesday, January 28th, Mac Armstrong sold 11,484 shares of Palomar stock. The stock was sold at an average price of $119.88, for a total value of $1,376,701.92.
- On Wednesday, January 21st, Mac Armstrong sold 5,000 shares of Palomar stock. The shares were sold at an average price of $129.00, for a total value of $645,000.00.
- On Thursday, January 15th, Mac Armstrong sold 2,310 shares of Palomar stock. The stock was sold at an average price of $130.00, for a total value of $300,300.00.
- On Friday, November 21st, Mac Armstrong sold 5,000 shares of Palomar stock. The shares were sold at an average price of $122.86, for a total value of $614,300.00.
Palomar Price Performance
NASDAQ PLMR traded up $5.09 on Friday, reaching $132.10. The stock had a trading volume of 455,917 shares, compared to its average volume of 258,007. The company has a market cap of $3.50 billion, a P/E ratio of 18.40 and a beta of 0.44. The firm has a fifty day moving average of $128.42 and a two-hundred day moving average of $123.23. Palomar Holdings, Inc. has a 1-year low of $107.75 and a 1-year high of $175.85.
Analyst Ratings Changes
PLMR has been the subject of several recent research reports. Weiss Ratings upgraded Palomar from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, January 14th. Wall Street Zen downgraded Palomar from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th. Evercore ISI assumed coverage on shares of Palomar in a research report on Monday. They set an “outperform” rating and a $150.00 price objective for the company. Keefe, Bruyette & Woods increased their price objective on shares of Palomar from $170.00 to $171.00 and gave the stock an “outperform” rating in a research note on Tuesday, January 6th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Palomar from $145.00 to $155.00 and gave the company an “overweight” rating in a research report on Wednesday, January 7th. Seven analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, Palomar has an average rating of “Moderate Buy” and a consensus target price of $158.14.
Read Our Latest Analysis on Palomar
Key Stories Impacting Palomar
Here are the key news stories impacting Palomar this week:
- Positive Sentiment: Q4 earnings and revenue beat consensus, driven by higher premiums and underwriting gains; management also raised its 2026 outlook — a primary driver of the stock’s strength. Palomar Q4 Earnings & Revenues Beat Estimates, Premiums Rise Y/Y
- Positive Sentiment: Brokerage coverage remains constructive — the consensus recommendation is around “Moderate Buy,” which supports continued investor interest. Palomar Given Average Recommendation of “Moderate Buy” by Brokerages
- Neutral Sentiment: Analyst/press deep-dive notes that Palomar’s diversification is driving top-line growth, but highlights emerging questions about margins and underwriting mix — watch margin trends in upcoming quarters. PLMR Q4 deep dive: Diversification drives growth, margin questions emerge
- Neutral Sentiment: Full Q4 earnings call transcript is available for detail on management’s commentary and guidance assumptions — useful for investors modeling forward earnings and loss ratios. Palomar Q4 2025 Earnings Call Transcript
- Negative Sentiment: Insider sale: CEO Mac Armstrong sold 5,000 shares at ~$122.60 (filed with the SEC), trimming his stake by ~1.44% — a potential sentiment headwind even though his remaining holding remains large. SEC Filing: Insider Sale
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently bought and sold shares of PLMR. Allworth Financial LP raised its stake in Palomar by 1,970.0% during the second quarter. Allworth Financial LP now owns 207 shares of the company’s stock worth $32,000 after acquiring an additional 197 shares in the last quarter. Salomon & Ludwin LLC acquired a new position in Palomar during the 3rd quarter worth approximately $25,000. Richardson Financial Services Inc. lifted its stake in Palomar by 210.0% in the 3rd quarter. Richardson Financial Services Inc. now owns 217 shares of the company’s stock valued at $25,000 after purchasing an additional 147 shares during the last quarter. Geneos Wealth Management Inc. acquired a new stake in Palomar in the fourth quarter valued at approximately $32,000. Finally, Hollencrest Capital Management grew its stake in shares of Palomar by 56.5% during the second quarter. Hollencrest Capital Management now owns 313 shares of the company’s stock worth $48,000 after buying an additional 113 shares during the last quarter. Institutional investors own 90.25% of the company’s stock.
About Palomar
Palomar Holdings, Inc (NASDAQ: PLMR) is a specialty insurance holding company focused on providing medical stop-loss coverage and related administrative services to self-funded employer health plans in the United States. The firm operates through two primary business segments—Medical Stop-Loss and Specialty Program Management—to deliver tailored risk protection and comprehensive program administration.
In its Medical Stop-Loss segment, Palomar underwrites excess and aggregate stop-loss policies designed to shield self-insured employers from catastrophic medical claims that exceed pre-determined retention levels.
Read More
- Five stocks we like better than Palomar
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Palomar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Palomar and related companies with MarketBeat.com's FREE daily email newsletter.
